News related to Sinografin (Diatrizoic Acid / Iodipamide Intrauterine) and/or conditions it is approved for
VIDA Diagnostics Gains FDA Approval For Comprehensive Lung Analysis Software
Source: Respiratory / Asthma News From Medical News Today [2008.11.29]
VIDA Diagnostics Inc. announced that its primary product, Pulmonary Workstation 2.0 (PW2) has obtained FDA 510(k) clearance for sale. PW2 is the first commercial release of lung image analysis software from VIDA and comprises a comprehensive approach to quantitative, repeatable lung measurements including the industry's first so-approved automatic lobe density and airway system measurement functions.
German Innovation For HIV/AIDS Diagnostics Has Been Used 2.5 Million Times In 2008
Source: HIV / AIDS News From Medical News Today [2008.11.29]
German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries. In the year 2008, 2.5 million patient tests have been performed with the portable, robust and highly affordable "CyFlow" system, supporting already more than 1 million people living with HIV/AIDS.
Prenatal Diagnostic Technology Allows Diagnosis Of Inherited Diseases Such As Cystic Fibrosis Caused By Single Gene Mutations
Source: Blood / Hematology News From Medical News Today [2008.11.25]
Sequenom, Inc. (NASDAQ:SQNM), announced that breakthrough data from a collaborative project with The Chinese University of Hong Kong, supporting the noninvasive prenatal diagnosis of monogenic diseases, were published online today in the Early Edition of the Proceedings of the National Academy of Sciences.
Cepheid Receives Health Canada License For First Molecular Diagnostic Test For MRSA And S. Aureus Soft Tissue Infections
Source: MRSA / Drug Resistance News From Medical News Today [2008.11.25]
Cepheid (Nasdaq: CPHD) announced that Health Canada has issued a medical device license for its Xpert(TM) MRSA/SA Skin and Soft Tissue (SSTI) test for the rapid detection of Methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA, typically Methicillin-sensitive) in skin and soft tissue infections.
Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis
Source: Prostate / Prostate Cancer News From Medical News Today [2008.11.24]
UroToday.com - A significant level of interest has developed in the association of prostate cancer (CaP) specific mortality (PCSM) with nutrition, lifestyle variables, and treatment effects. The data surrounding a man's body mass index (BMI) and PCSM is mixed, but likely suggest an association between high BMI and an increased risk of dying from CaP. But is there a test that links obesity with this increased risk? In the online edition of Lancet Oncology, Dr. Jing Ma and associates of Dr.
FDA 510(k) Clinical Trial Progress For AppyScore, World's First Blood-Based Diagnostic Test For Human Appendicitis
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2008.11.21]
AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, reported the enrollment level in the ongoing FDA 510(k) clinical trial for AppyScore(TM), the world's first blood-based diagnostic test for human appendicitis exceeds 700 patients.
Michelson Diagnostics To Demonstrate Prototype Hand-Held OCT Probe At BIOS 09
Source: Dermatology News From Medical News Today [2008.11.19]
Michelson Diagnostics has announced that it will demonstrate its prototype multi-beam Optical Coherence Tomography (OCT) probe at the BIOS Exhibition at SPIE Photonics West, San Jose, 24-25th January 2009 (Stand 8731). More than one variant of the new probe will be launched later in 2009, including a dermal version (with X-Y scanning, to enable 3D mapping of skin lesions) and a version equipped with a rigid endoscope, suitable for oral applications.
PSA Test Losing Diagnostic Value, Study Says
Source: MedicineNet Prostate Specific Antigen Specialty [2008.03.11]
Title: PSA Test Losing Diagnostic Value, Study Says
Category: Health News
Created: 3/11/2008 2:00:00 AM
Last Editorial Review: 3/11/2008
Angina - Diagnostic Tests
Source: MedicineNet Coronary Artery Disease Screening Tests (CAD) Specialty [2007.02.06]
Title: Angina - Diagnostic Tests
Category: Ask The Experts
Created: 2/6/2007
Last Editorial Review: 2/6/2007
Diagnostic Methods for Insect Sting Allergy
Source: Medscape Primary Care Headlines [2004.08.25]
This review overviews advances from mid-2002 to the present in the validation and performance methods used in the diagnosis of Hymenoptera venom-induced immediate-type hypersensitivity. (CME)
Oxoid Offers Range Of Tests For Influenza Virus Types A And B
Source: Respiratory / Asthma News From Medical News Today [2008.11.28]
Oxoid, a world leading microbiology brand, offers a range of valuable diagnostic tools for the detection of respiratory disease caused by influenza virus Types A and B. Rapid diagnosis of Influenza A or B virus infections plays an important role in patient management, influencing the use of antiviral therapy and enabling effective management and control of outbreaks. Influenza virus infections peak in the winter months1 and remain a major health concern.
Exonhit Launches Mouse Genome Splicearraytm For Use In Human Disease Modeling Studies
Source: Genetics News From Medical News Today [2008.11.28]
ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray™ for use in studying mouse models of human disease. These SpliceArrayTM products help our clients accelerate and refine their therapeutic target discovery and validation efforts.
Is The Future Of Healthcare Wireless? Debate, England
Source: IT / Internet / E-mail News From Medical News Today [2008.11.27]
4TH December 2008, Nucleus, Chesterford Park, Cambs CB10 1TS, England. Intelligent microchip-based body monitoring systems are enabling a new generation of healthcare management applications. By bringing innovators in the fields of wireless communication and medical device and diagnostic technologies together with potential end-users, this facilitated workshop promises to be a lively and stimulating event.
'Barcode Chip' Developed For Cheap, Fast Blood Tests
Source: Blood / Hematology News From Medical News Today [2008.11.26]
A new "barcode chip" developed by researchers at the California Institute of Technology (Caltech) promises to revolutionize diagnostic medical testing. In less than 10 minutes, and using just a pinprick's worth of blood, the chip can measure the concentrations of dozens of proteins, including those that herald the presence of diseases like cancer and heart disease.
Ipsogen Launches A New Test To Determine Tumor HER2 Status And Guide Herceptin(R) Prescription In Breast Cancer
Source: Breast Cancer News From Medical News Today [2008.11.25]
IPSOGEN SA (Marseille, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukemia and breast cancer announced the European launch of MapQuant Dx(TM) HER2 test. Developped on the MapQuant Dx(TM) microarray diagnostic platform, MapQuant Dx(TM) HER2 accurately measures a set of HER2-amplified genes that correlate with HER2 protein expression.
Women's Health 2009: The 17th Annual Congress
Source: Conferences News From Medical News Today [2008.11.24]
A prestigious group of physicians, nurses, and allied healthcare providers will gather in Williamsburg, VA on March 27-29, 2009 at the Williamsburg Lodge to learn practical, clinical information on cutting-edge therapeutic protocols, novel diagnostic procedures, and innovative research advances that impact patient care. The full program, faculty, accreditation, and registration information is available at
EMR At 1.5 Tesla To Assess Local Recurrence After Radical Prostatectomy Using T2-Weighted & Contrast-Enhanced Imaging
Source: Prostate / Prostate Cancer News From Medical News Today [2008.11.24]
UroToday.com - Imaging accuracy for local recurrence of prostate cancer (CaP) and the use of endorectal magnetic resonance (eMR) has not been significantly assessed. In the online version of European Radiology, Dr. Stefano Cirillo and colleagues from Italy evaluated the diagnostic performance of eMR for diagnosing local CaP recurrence following radical prostatectomy (RP) in the face of an increasing serum PSA level.
FDA Device Reviewers Allege Agency Coerces Unsound Judgments
Source: MedPage Today Product Alert [2008.11.20]
WASHINGTON (MedPage Today) -- Some FDA reviewers of devices and diagnostic products have protested to a congressional committee that they have been pressured into approval recommendations that were against their best scientific judgments.
First At Home Test For Vasectomized Men Proves To Be Safe, Accurate
Source: Fertility News From Medical News Today [2008.11.14]
In a report now available online and scheduled to be the cover story of the December 2008 issue of the Journal of Urology, University of Virginia Health System researcher John C. Herr, PhD and his colleagues have confirmed the accuracy and reliability of SpermCheck Vasectomy, the first FDA approved at-home immunodiagnostic test for detecting low concentrations of sperm.
Atherotech To Exhibit VAP(R) Cholesterol Test At American Heart Association Scientific Sessions 2008
Source: Cholesterol News From Medical News Today [2008.11.07]
Atherotech, Inc., a cardio-diagnostic company, today announced it will be exhibiting its VAP(R) Cholesterol Test in booth No. 2918 at the American Heart Association Scientific Sessions 2008. The annual meeting takes place Nov. 8-12 at the Ernest N. Morial Convention Center in New Orleans. Atherotech representatives will be available to discuss the VAP Cholesterol Test during regular exhibit hours on October 9, 10 and 11 in booth No.
Source MDx And Brigham And Women's Hospital Partner To Study RNA-Based Biomarkers For Multiple Sclerosis
Source: Multiple Sclerosis News From Medical News Today [2008.11.04]
Source MDx today announced a partnership with Brigham and Women's Hospital in Boston to examine RNA-based biomarkers in multiple sclerosis (MS) patients and healthy control participants unaffected by the disease. The goal of the study is to identify diagnostic markers and to determine markers of active disease (relapses) or stable disease, along with response markers for currently available MS therapies.
25 New Awards To Develop Radiation Countermeasures Announced By NIAID
Source: Bio-terrorism / Terrorism News From Medical News Today [2008.10.08]
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 25 new grants to develop new and better diagnostics and treatments for radiation exposure after a nuclear attack.
Ulcerative Colitis/Stercoralis Infection
Source: Headache / Migraine News From Medical News Today [2008.09.24]
Although exacerbation of UC usually poses little diagnostic dilemma, physicians should remain cognizant to the possibility of an alternative cause for patient symptoms. An article published in the World Journal of Gastroenterology addresses this report. The research team led by Prof.
Mad Cow Disease Also Caused By Genetic Mutation Research Shows
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2008.09.12]
New findings about the causes of mad cow disease show that sometimes it may be genetic. "We now know it's also in the genes of cattle," said Juergen A. Richt, Regents Distinguished Professor of Diagnostic Medicine and Pathobiology at Kansas State University's College of Veterinary Medicine. Until several years ago, Richt said, it was thought that the cattle prion disease bovine spongiform encephalopathy -- also called BSE or mad cow disease -- was a foodborne disease.
Abviva, Inc.: New Case Of Mad Cow Disease Detected In North America
Source: CJD / vCJD / Mad Cow Disease News From Medical News Today [2008.07.03]
Abviva, Inc. (OTCBB: AVVA) announced that BioBDC International (BioBDC), Abviva's exclusive sales agent for Mad Cow diagnostic tests produced by Abviva's subsidiary company Prion Developmental Laboratories, Inc. (PDL), reported the Canadian Food Inspection Agency confirmed a new case of mad cow disease, bovine spongiform encephalopathy (BSE), was discovered in western Canada, increasing consumer's concerns over beef safety.
|
